Citations Report
International Journal of Clinical Rheumatology : Citations & Metrics Report
Articles published in International Journal of Clinical Rheumatology have been cited by esteemed scholars and scientists all around the world.
International Journal of Clinical Rheumatology has got h-index 34, which means every article in International Journal of Clinical Rheumatology has got 34 average citations.
Following are the list of articles that have cited the articles published in International Journal of Clinical Rheumatology.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
59 | 49 | 39 | 47 | 58 |
Year wise citations received |
582 | 651 | 520 | 511 | 461 |
Journal total citations count | 5529 |
Journal impact factor | 11.84 |
Journal 5 years impact factor | 10.98 |
Journal cite score | 11.91 |
Journal h-index | 34 |
Journal h-index since 2018 | 27 |
Journal Impact Factor 2020 formula |
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
Journal 5-year Impact Factor 2020 formula |
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
Journal citescore |
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., & Hudson, A. P. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?. International journal of clinical rheumatology, 6(3), 333.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Davidson, A. Future advances in pharmacogenomics: BAFF, APRIL and plasma cells. International Journal of Clinical Rheumatology, 5(3), 281. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Szekanecz, Z., & Koch, A. E. VEGF as an activity marker in rheumatoid arthritis. International Journal of Clinical Rheumatology, 5(3), 287.(2010) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Cavalli, L., & Brandi, M. L. Age-and gender-related macro-and micro-architecture changes in bone structure and implications for treatment. International Journal of Clinical Rheumatology, 6(3), 359.(2011) View at Publisher | View at Google Scholar | View at Indexing
- Mosca, M., & Carmona, L. Assessment of multiple organ systems in systemic lupus erythematosus: what will the new guidelines mean?. International Journal of Clinical Rheumatology, 5(3), 291. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Mosca, M., & Carmona, L. Assessment of multiple organ systems in systemic lupus erythematosus: what will the new guidelines mean?. International Journal of Clinical Rheumatology, 5(3), 291. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Ayensa, J. L., & Ruiz-Irastorza, G.A new role for antimalarials in systemic lupus erythematosus treatment. International Journal of Clinical Rheumatology, 5(3), 299. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Ayensa, J. L., & Ruiz-Irastorza, G.A new role for antimalarials in systemic lupus erythematosus treatment. International Journal of Clinical Rheumatology, 5(3), 299. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Ayensa, J. L., & Ruiz-Irastorza, G.A new role for antimalarials in systemic lupus erythematosus treatment. International Journal of Clinical Rheumatology, 5(3), 299. (2010) View at Publisher | View at Google Scholar | View at Indexing
- Ayensa, J. L., & Ruiz-Irastorza, G.A new role for antimalarials in systemic lupus erythematosus treatment. International Journal of Clinical Rheumatology, 5(3), 299. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing
- De Achaval, S., & Suarez-Almazor, M. E. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. International journal of clinical rheumatology, 5(3), 313. (2010) View at Publisher | View at Google Scholar | View at Indexing